Work

Continuation of antiplatelet and anticoagulant therapy during endoscopic variceal band ligation is not associated with increased rates of post-banding bleeding: an Australian retrospective analysis

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Aims There is little evidence to guide the management of antiplatelets/anticoagulants (AP/AC) during endoscopic variceal band ligation (EVBL). This study aims to assess bleeding complications following EVBL performed with AP/AC. Methods We retrospectively assessed all EVBL cases performed at our centre over a 10-year period (January 2010 to August 2020), comparing outcomes of those on AP/AC during EVBL versus those not on AP/AC. Secondary analysis was of patients continuing AP/AC versus those who withheld usual AP/AC. Results A total of 1,570 episodes of EVBL were analysed (116 AP/AC, 1,454 off AP/AC). Mean age was 56.2 years, 75.6% were male, and mean model for end stage liver disease score was 14. No difference was found between groups for 30-day bleeding rates (3/116 cases [2.6%] on AP/AC, 52/1,454 cases [3.6%] off AP/AC, p =0.58), or overall 30-day mortality (3/116 cases [2.6%] on AP/AC, 18/1,454 cases [1.2%] off AP/AC, p =0.22). Similarly, 30-day bleeding rates did not differ between AP/AC patients continuing (3/110 cases [2.7%]) versus those withholding therapy (6/123 cases [4.9%], p =0.40). Conclusions In a large cohort of patients undergoing EVBL, continuation of AP/AC therapy was not associated with an elevated risk of rebleeding. This adds further evidence to support current recommendations to continue such therapy for patients undergoing endoscopy for varices.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $242
OpenAlex ID: W7235462364
FWCI:
Cites: 11
Cited by:
Related to: 10